After examining five year data, researchers now advise against the use of multiple courses of steroids in premature infants. These findings are contrary to those gathered previously by a Cochrane review.
This review may be the first long-term, follow-up study to identify a subject group of infants who did not benefit from multiple course steroids. Evidence showed an increased risk of a difficulty later on in childhood.
Though giving a second course of steroids may improve the initial breathing short term, giving or not giving a second course does not appear to have an increased benefit when looking into the survival of the infant or how the child will be in five years.
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.